SwePub
Sök i LIBRIS databas

  Extended search

WFRF:(Syk Ingvar)
 

Search: WFRF:(Syk Ingvar) > Cytoreductive surge...

  • Cashin, Peter H.Uppsala universitet,Kolorektalkirurgi (author)

Cytoreductive surgery and intraperitoneal chemotherapy versus systemic chemotherapy for colorectal peritoneal metastases : A randomised trial

  • Article/chapterEnglish2016

Publisher, publication year, extent ...

  • Elsevier BV,2016
  • printrdacarrier

Numbers

  • LIBRIS-ID:oai:DiVA.org:uu-280096
  • https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-280096URI
  • https://doi.org/10.1016/j.ejca.2015.09.017DOI
  • https://lup.lub.lu.se/record/8592453URI
  • http://kipublications.ki.se/Default.aspx?queryparsed=id:132854040URI

Supplementary language notes

  • Language:English
  • Summary in:English

Part of subdatabase

Classification

  • Subject category:ref swepub-contenttype
  • Subject category:art swepub-publicationtype

Notes

  • Background: First-line treatment of isolated resectable colorectal peritoneal metastases remains unclear. This study (the Swedish peritoneal study) compares cytoreductive surgery and intraperitoneal chemotherapy (surgery arm) with systemic chemotherapy (chemotherapy arm). Methods: Patients deemed resectable preoperatively were randomised to surgery and intraperitoneal 5-fluorouracil 550 mg/m(2) /d for 6 d with repeated courses every month or to systemic oxaliplatin and 5-fluorouracil regimen every second week. Both treatments continued for 6 months. Primary end-point was overall survival (OS) and secondary end-points were progression-free survival (PFS), and morbidity. Results: The study terminated prematurely when 48 eligible patients (24/arm) were included due to recruitment difficulties. Two-year OS was 54% in the surgery arm and 38% in the chemotherapy arm (p = 0.04). After 5 years, 8 versus 1 patient were alive, respectively (p = 0.02). Median OS was 25 months versus 18 months, respectively, hazard ratio 0.51 (95% confidence interval: 0.27-0.96, p = 0.04). PFS in the surgery arm was 12 months versus 11 months in the chemotherapy arm (p = 0.16) with 17% versus 0% 5-year PFS. Grade III-IV morbidity was seen in 42% and 50% of the patients, respectively. No mortalities. Conclusions: Cytoreductive surgery with intraperitoneal chemotherapy may be superior to systemic oxaliplatin-based treatment of colorectal cancer with resectable isolated peritoneal metastases.(ClinicalTrials. gov nr: NCT01524094).

Subject headings and genre

Added entries (persons, corporate bodies, meetings, titles ...)

  • Mahteme, HaileUppsala universitet,Institutionen för kirurgiska vetenskaper,Uppsala Canc Clin, Uppsala, Sweden.(Swepub:uu)hailmaht (author)
  • Spang, N.Uppsala universitet,Institutionen för kirurgiska vetenskaper (author)
  • Syk, IngvarLund University,Lunds universitet,Kirurgi,Forskargrupper vid Lunds universitet,Surgery,Lund University Research Groups(Swepub:lu)kir-isy (author)
  • Frodin, J. E.Karolinska Institutet (author)
  • Torkzad, MichaelUppsala universitet,Radiologi (author)
  • Glimelius, BengtUppsala universitet,Experimentell och klinisk onkologi,Karolinska Inst, Dept Pathol & Oncol, S-17176 Stockholm, Sweden.(Swepub:uu)bengglim (author)
  • Graf, WilhelmUppsala universitet,Kolorektalkirurgi(Swepub:uu)wilhgraf (author)
  • Uppsala universitetKolorektalkirurgi (creator_code:org_t)

Related titles

  • In:European Journal of Cancer: Elsevier BV53, s. 155-1620959-80491879-0852

Internet link

Find in a library

To the university's database

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view